Pharmalot Ed Silverman Despite court ruling, FDA will continue with its approach to approving orphan drug exclusivity
Pharmalot Ed Silverman Pharmalittle: Obesity guidelines cause backlash; Bayer is pushed to spin off its consumer health business
Health Tech Casey Ross As more never-smokers develop lung cancer, researchers test an AI model to predict patient risk
Biotech Allison DeAngelis How one private biotech seized on JPM to emerge from stealth and tell its story
Biotech Ryan Cross — The Boston Globe ‘Holding on by its fingernails.’ The biotech industry in Massachusetts braces for another tough year
Pharmalot Ed Silverman FTC wants ‘pharma bro’ Martin Shkreli held in contempt for violating lifelong ban on working in pharma
Pharmalot Ed Silverman Pharmalittle: FDA rejects Lilly application for Alzheimer’s drug; Sanofi offers a warranty for a medicine
Pharmalot Ed Silverman ‘A cascade of failures’: FDA cites Indian drugmaker for numerous quality control problems
Pharmalot Ed Silverman and John Wilkerson Pallone pushes NIH and FDA to disclose steps being taken to ensure clinical trial results are reported
Pharmalot Ed Silverman Pharmalittle: India regulator finds 5% of drug samples are substandard; EMA claims new clinical trial registry is fixed
Exclusive Matthew Herper and Casey Ross Verily leans into Onduo as it looks to enter the lucrative world of running medical research
Pharmalot Ed Silverman Pharmalittle: HIV vaccine study is stopped early; Merck has a plan to combat carcinogen found in diabetes drugs
Business Tara Bannow Hip and knee replacements go better when performed by high-volume surgeons, new study finds
Pharmalot Ed Silverman Major purchasers predict expensive new therapies will keep driving drug price hikes
Biotech Matthew Herper Moderna says RSV vaccine worked, setting stage for competition with GSK and Pfizer
Pharmalot Ed Silverman Pfizer says it will widen access to hundreds of off-patent medicines in low-income countries
Pharmalot Ed Silverman Pharmalittle: Lilly and AbbVie exit U.K. drug-pricing program; J&J scales back Covid-19 vaccine production
Pharmalot Ed Silverman Large health insurers lowered barriers to fair access to some drugs, analysis finds
Opinions+ Christine Swisher and Gabriel Seidman 4 concrete steps to realize the AI Bill of Rights for clinical decision support software
Biotech Jonathan Wosen Liquid biopsy study suggests a better way to decide which colorectal cancer patients need chemo
Politics John Wilkerson Congressional Medicare advisers warn of higher drug prices, despite new price negotiation
Health Tech Mohana Ravindranath ‘We’re no exception’: Why Carbon Health is changing course as economic pressures mount